Gline Matthew sold ROIV
March 30, 2026 · Form 4 insider transaction
Gline Matthew sold 53,826 shares of Roivant Sciences Ltd. at $26.41 per share, a transaction worth $1.42M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
53,826
Price
$26.41
Total value
$1.42M
InsiderGline Matthew
RoleOfficer, Director
CompanyRoivant Sciences Ltd. (ROIV)
SecurityCommon Shares
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 30, 2026
Filing dateApril 1, 2026
Shares owned after17,330,574
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the "net settlement" by the Issuer of CVARs in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such CVARs.